Zobrazeno 1 - 10
of 185
pro vyhledávání: '"Short daily hemodialysis"'
Autor:
Ana Beatriz Lesqueves Barra, Ana Paula Roque-da-Silva, Marcos S. Vasconcellos, Jocemir R. Lugon, Jorge Paulo Strogoff-de-Matos
Publikováno v:
BMC Nephrology, Vol 21, Iss 1, Pp 1-8 (2020)
Abstract Background Fluid overload (FO) assessed by bioimpedance spectroscopy (BIS) is associated with higher mortality risk in maintenance haemodialysis (HD). The aim was to assess if a better management of FO through short daily haemodialysis (SDHD
Externí odkaz:
https://doaj.org/article/cc2d569a907b4e18b751905644b2a749
Autor:
J.L. Jiang, W. Ren, J. Song, Q.L. Sun, X.Y. Xiao, X.Z. Diao, Y.H. Huang, L. Lan, P. Wang, Z. Hu
Publikováno v:
Brazilian Journal of Medical and Biological Research, Vol 46, Iss 7, Pp 629-633 (2013)
Anemia is a frequent complication in hemodialysis patients. Compared to conventional hemodialysis (CHD), short daily hemodialysis (sDHD) has been reported to be effective in many countries except China. The aim of the present study was to determine w
Externí odkaz:
https://doaj.org/article/e1a1fbaef11d4b909abd6a968a1e7eb4
Publikováno v:
Kidney International Reports. 5(11):1856-1869
Hemodialysis has saved many lives, albeit with significant residual mortality. Although poor outcomes may reflect advanced age and comorbid conditions, hemodialysis per se may harm patients, contributing to morbidity and perhaps mortality. Systemic c
Publikováno v:
INTERNATIONAL UROLOGY AND NEPHROLOGY
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
r-FISABIO. Repositorio Institucional de Producción Científica
instname
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
r-FISABIO. Repositorio Institucional de Producción Científica
instname
Among the different hemodialysis (HD) strategies, the short daily hemodialysis performed at home (SDHHD) provides clinical benefits to the patient. Expanded hemodialysis (HDx) employs cutoff medium membranes that exhibit greater clearance capacity of
Autor:
Pablo Urena, Maxime Touzot, Patricia Villie, Christophe Ridel, Florence Vendé, Maxime Dauvergne, Catherine Maheas
Publikováno v:
Journal of Nephrology
Autor:
Andreas Maierhofer, Allan J. Collins, Jeroen P. Kooman, Nicholas M. Selby, Peter Kotanko, Maarten W. Taal, Bernard Canaud, Susan T. Francis, Pascal Kopperschmidt
Publikováno v:
Kidney International Reports
Kidney International Reports, Elsevier, 2020, 5, pp.1856-1869. ⟨10.1016/j.ekir.2020.08.031⟩
Kidney International Reports, Elsevier, 2020, 5, pp.1856-1869. ⟨10.1016/j.ekir.2020.08.031⟩
Hemodialysis has saved many lives, albeit with significant residual mortality. Although poor outcomes may reflect advanced age and comorbid conditions, hemodialysis per se may harm patients, contributing to morbidity and perhaps mortality. Systemic c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a00f01ad6d52ce0698f75804212b65e
https://hal.archives-ouvertes.fr/hal-03492857
https://hal.archives-ouvertes.fr/hal-03492857
Publikováno v:
Advances in chronic kidney disease. 28(2)
Home hemodialysis (HHD), performed more frequently than in-center hemodialysis, is underutilized in the United States but has had a recent resurgence driven predominantly by innovative dialysis equipment that is easy to use, less intrusive to the hom
Publikováno v:
Annals of Pharmacotherapy. 53:348-356
Background: A number of centers across the world offer short daily hemodialysis (SDHD) treatments. To date, cefazolin pharmacokinetics have not been described in patients undergoing SDHD. Objective: The purpose of this study was to investigate the ef
Publikováno v:
BMC Nephrology
BMC Nephrology, 2019, 20 (1), pp.156. ⟨10.1186/s12882-019-1330-1⟩
BMC Nephrology, BioMed Central, 2019, 20 (1), pp.156. ⟨10.1186/s12882-019-1330-1⟩
BMC Nephrology, Vol 20, Iss 1, Pp 1-9 (2019)
BMC Nephrology, 2019, 20 (1), pp.156. ⟨10.1186/s12882-019-1330-1⟩
BMC Nephrology, BioMed Central, 2019, 20 (1), pp.156. ⟨10.1186/s12882-019-1330-1⟩
BMC Nephrology, Vol 20, Iss 1, Pp 1-9 (2019)
Background As patients on daily hemodialysis (DHD) have heterogeneous profiles, DHD benefit in terms of survival is still debated. The aim of this study was to compare DHD practices in France and in Australia and New Zealand. Methods This study was b
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.